Abstract:The hygiene hypothesis suggests that helminth infections can reduce hypersensitivity in the immune system. This study aimed to evaluate the effects of Toxocara cati somatic products on allergic airway inflammation. These findings suggest that T. cati somatic extract has the potential as a therapeutic agent for attenuating allergic airway inflammation by modulating immune responses and reducing inflammatory cell infiltration. Background The hygiene hypothesis suggests that early life exposure to helminth infections can reduce hypersensitivity in the immune system. Objective The present study aims to evaluate the effects of Toxocara cati (T. cati) somatic products on allergic airway inflammation. Methods Between 2018 and 2020, T. cati adult worms were collected from stray cats in Mashhad, Iran (31 out of 186 cats), and their somatic extract was collected. Thirty BALB/c mice were equally divided into three groups, including the OVA group (sensitized and challenged with ovalbumin), the somatic administered group (received somatic extract along with ovalbumin sensitization), and the PBS group (sensitized and challenged with phosphate buffer saline). Bronchoalveolar lavage (BAL) fluid was collected to assess the number of cells, and lung homogenates were prepared for cytokine analysis. Histopathological analysis of the lungs was performed, and inflammatory cells and mucus were detected. Cytokine levels (IL‐4, IL‐5, IL‐10) were measured using enzyme‐linked immunosorbent assay (ELISA), and ovalbumin‐specific immunoglobulin E (IgE) levels were determined using a capture ELISA. Results The somatic group significantly decreased regarding the lung pathological changes, including peribronchiolitis, perivasculitis, and eosinophil influx, compared to the group treated with ovalbumin alone. These changes were accompanied by a decrease in proinflammatory cytokines IL‐4 and IL‐5 and an increase in the anti‐inflammatory cytokine IL‐10, indicating a shift toward a more balanced immune response. The number of inflammatory cells in the BAL fluid was also significantly reduced in the somatic group, indicating a decrease in inflammation. Conclusion These preclinical findings suggest that in experimental models, T. cati somatic extract exhibits promising potential as a therapeutic agent for mitigating allergic airway inflammation. Its observed effects on immune response modulation and reduction of inflammatory cell infiltration warrant further investigation in clinical studies to assess its efficacy and safety in human patients.

The management of labor in women with more than one uterine scar: Is a repeat cesarean section really the only “safe” option?

Epidemiological investigation of feline chronic gingivostomatitis and its relationship with oral microbiota in Xi'an, China

Topical indocyanine green antimicrobial photodynamic therapy for refractory feline chronic gingivostomatitis: A case report

Moderate to advanced periodontitis contributes to increased oxidative stress in cats: a case-control study

Characterization of Oral Microbiota in Cats: Novel Insights on the Potential Role of Fungi in Feline Chronic Gingivostomatitis

Feline chronic gingivostomatitis current concepts in clinical management

Failure of a dietary model to affect markers of inflammation in domestic cats

Feline pemphigus foliaceus in non-specialist veterinary practice: a retrospective analysis

Feline Chronic Gingivostomatitis Diagnosis and Treatment through Transcriptomic Insights

Proof‐of‐concept study of anti‐Fel d 1 IgY antibodies in cat food using the MASK‐air ® app

Clinicopathological findings and clinical outcomes in 49 cases of feline pemphigus foliaceus examined in Northern California, USA (1987-2017)

[Functional interactions between uterine tube and fertilized egg].

Bifidobacterium lactis and Lactobacillus plantarum Enhance Immune Function and Antioxidant Capacity in Cats through Modulation of the Gut Microbiota

Effect of Dietary Composite Probiotic Supplementation on the Microbiota of Different Oral Sites in Cats

Use of prednisolone as monotherapy in the treatment of feline pemphigus foliaceus: a retrospective study of 37 cats

Evaluating the Toxocara cati extract as a therapeutic agent for allergic airway inflammation

Beneficial effect of oclacitinib in a case of feline pemphigus foliaceus

115 Effects of Probiotic and Heat-Killed Probiotic Supplementation on Systemic Biomarkers of Oxidative Stress and Inflammation and Fermentative end Products of Adult Cats

The polymicrobial nature of the oral cavity and claws of cats diagnosed by mass spectrometry and next-generation sequencing

Feline pemphigus foliaceus: original case series and a comprehensive literature review

Case report: Complete clinical remission of feline progressive histiocytosis after multimodal treatment including electrochemotherapy